GCI Health has announced two appointments in Singapore:

• Mike Tegg is now Director of Public Health Policy. He brings 13 years of experience in public service, politics, and health policy to his new role, most recently with Novartis and Johnson & Johnson, respectively. He has also served in advisory and press secretary roles for Australian government agencies and the Australian Labor Party. In his new role, Mike will work to overlapping political, media and business environments in the region, on behalf of its public affairs and government relations client partners.
• James Keng Lim has started as Director of Creative Strategy. He joins from Singapore’s Ministry of Health and has spent close to 20 years working in senior creative positions for agencies including Publicis, Dentsu and Ogilvy via roles based out of Singapore, Malaysia, Australia, China and Dubai.

Both Mike and James will lead the growth of their respective specialities for the agency’s six Asia Pacific offices.

“James and Mike are two of Asia’s most specialised experts in their fields, and their joining reflects the importance we place on creative strategy and public health policy to the future of our business,” said Rikki Jones, President, GCI Health Asia Pacific. “Having launched a specialised medical strategy and education offer in 2022 to huge success, the time is now right to further expand our specialised capabilities, evolving how we contribute to improved patient and health system outcomes across Asia.”